KINGSTON, R.I.—Imagine if you could find out, decades ahead of time, whether you are going to suffer from Alzheimer’s disease. Now imagine if you could detect those signs through an eye scan—rather than through the invasive, expensive tests that doctors now use. That is the potential of a clinical trial involving the University of Rhode Island, Butler Hospital’s Clinical and Aging Program, and Florida’s BayCare Health System. According to a recent story from the Boston Globe, on Monday the three organizations announced the launch of a five-year, $5 million clinical trial of a retinal screening process that could help detect Alzheimer’s more than two decades before symptoms appear. The study is seeking 300 volunteers between the ages of 55 and 80. Click here to read the full story.